Form 8-K - Current report:
SEC Accession No. 0001104659-21-062016
Filing Date
2021-05-06
Accepted
2021-05-06 07:07:13
Documents
15
Period of Report
2021-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2115162d1_8k.htm   iXBRL 8-K 27439
2 EXHIBIT 99.1 tm2115162d1_ex99-1.htm EX-99.1 177412
7 GRAPHIC image_002.jpg GRAPHIC 6690
  Complete submission text file 0001104659-21-062016.txt   439393

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA irwd-20210506.xsd EX-101.SCH 3205
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE irwd-20210506_def.xml EX-101.DEF 26584
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE irwd-20210506_lab.xml EX-101.LAB 34592
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE irwd-20210506_pre.xml EX-101.PRE 22723
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2115162d1_8k_htm.xml XML 3629
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

EIN.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34620 | Film No.: 21895737
SIC: 2834 Pharmaceutical Preparations